Merck has acquired all ownership rights to the ProcessPad™ platform from Simplyfeye Softwares Private Limited. The
agreement includes the transfer of all copyrights and relevant intellectual property related to this software
The acquisition of the platform is another building block for Merck’s BioContinuum™ Platform, a confluent offering of intensified, advanced processing and digital technologies and services that allow a customer to go beyond continuous processing. The BioContinuum™ Platform will deliver contiguous manufacturing for Biopharma 4.0, the industry-specific global vision and initiative based on Industry 4.0.